Latest Industry News & Trends
Market Scope provides comprehensive coverage of the ophthalmic market. Our news stories are a combination of public and proprietary content ranging from coverage of international meetings, surgeon survey results and trends, analysis of company financial reports and public medical registries, press releases, and interviews with executives. Register today to receive free weekly email updates, our top data chart, surgeon poll results, and much more. Locked content can be accessed through a subscription to our ophthalmic industry newsletters.
Recently Added News
Cencora to Acquire EyeSouth Partners’ Retina Business for $1.1 Billion
Cencora announced March 23 that it had agreed to acquire the retina business of EyeSouth Partners for $1.1 billion. The move follows Cencora’s $4.6 billion deal in January 2025 to buy Retina Consul...
Regulators in China Approve Lotilaner Drops, Triggering $15 Million Payment to Tarsus
Tarsus Pharmaceuticals announced March 23 that regulators in China had approved TP-03 (lotilaner ophthalmic solution) 0.25%, its mite-killing treatment targeting Demodex blepharitis that is markete...
2025 Ophthalmic Revenue Roundup for Iridex and Lenz
Iridex, of Mountain View, California, reported March 26 that its 2025 revenue was $52.7 million, an 8 percent increase over $48.7 million in 2024. Cyclo G6 product revenue was $13.8 million, a 9 pe...
2026 APAO Meeting in Hong Kong Attracts Surgeons from 111 Countries
Over 11 thousand eye care professionals met Feb. 4-7 in Hong Kong to exchange ideas and debate the strategies for managing eye diseases at the 2026 congress of the Asia-Pacific Academy of Ophthalmo...
J&J Continues to Reduce JLABS Footprint with Exit from New York
Johnson & Johnson is stepping away from its JLABS incubator site in New York, reducing its JLABS locations in the US to those in San Diego, San Francisco, and Boston. The New York site opened in 20...
Zeiss Expands Clinical Ophthalmic and Optometric Device Portfolio in Canada
Carl Zeiss Meditec announced March 24 the addition of several advanced diagnostic, visualization, and therapeutic devices to its ophthalmic and optometric portfolio in Canada. Zeiss said its Clarus...
Innovent Reports Positive Phase III Results for Extended-Dosing Retinal Candidate
China’s Innovent Biologics reported March 23 that IBI302 (efdamrofusp alfa), its extended-dosing retinal candidate, met its primary visual acuity endpoint at week 52 in the Phase III STAR study. IB...
Lineage Launches New Cell Therapy Program in Corneal Endothelial Disease
Lineage Cell Therapeutics announced March 24 that it had expanded its cell transplant pipeline to include COR1, a corneal endothelial cell therapy candidate in preclinical development. Lineage, of ...
US FDA Grants Orphan Drug Status to Sumitomo’s RP Cell Therapy Candidate
Japan’s Sumitomo Pharma announced March 23 that the US FDA had granted orphan drug status to DSP-3077, its allogeneic retinal sheets in Phase I/II study for retinitis pigmentosa. Orphan drug design...
2026 AGS Meeting Showcases Products Designed for Earlier Intervention
Sessions at the 2026 American Glaucoma Society meeting spotlighted a wave of emerging technologies—from next-generation endoscopic cyclophotoco-agulation and transscleral laser therapy to ultrathin...
Ophthalmologists Report 2.1 Percent Decrease in Q4-2025 Procedure Volume
------ Refractive: -17.3 IOL: +5.0 Glaucoma: +4.2 Retina: -5.7 ----- US ophthalmologists reported that ophthalmic procedures decreased 2.1 percent in Q4-2025 compared with the same quarter in 2024,...
Ophthalmic Company Revenue Down 1.8 Percent in Q4-2025; Seven Firms See Declines
Ophthalmic manufacturer revenue in Q4-2025 totaled $11.8 billion. Revenue decreased 1.8 percent from the same quarter in 2024 and increased 2.5 percent from Q3-2025. The total includes Market Scope...
Past News Stories
Premium IOLs Move Mainstream as Revenue Growth Accelerates Globally
The unprecedented premium IOL growth seen over the past five years is expected to continue over the next five years, with premium IOL revenue projected to account for $5.4 billion and 57 percent of...
J&J Vision Gains US FDA Approval for Tecnis PureSee EDOF IOL
Johnson & Johnson Vision announced March 12 that it had gained US FDA approval for the Tecnis PureSee, an extended depth of focus (EDOF) intraocular lens (IOL) for use in cataract surgery. The Jack...
Alcon, Lensar Scrap Acquisition Deal in Face of FTC Opposition
Alcon and Lensar reported March 16 that they were terminating Alcon’s $430 million acquisition of the cataract laser company, in the wake of opposition from the US Federal Trade Commission (FTC). L...
Meet with Market Scope at the ASCRS Meeting
Market Scope will be exhibiting at Booth 323 at the 2026 ASCRS meeting, set for April 10-13 in Washington, DC. Contact us to set up a time to discuss your custom research needs. Reach us at 314-835...
Select US FDA Approvals and Clearances in February 2026
The US FDA’s ophthalmic device division granted clearance to one device using the 510(k) pathway in February 2026, according to the agency’s database. Quantel Medical received clearance for its Int...
PDUFA Dates for Ophthalmic Drug Candidates, March 2026
The US FDA has scheduled the following Prescription Drug User Fee Act (PDUFA) target action dates for ophthalmic drug, drug/device, and biologic candidates.
US FDA Rejects Chiesi’s Idebenone for LHON, Asks for More Clinical Data
Chiesi reported March 5 that the US FDA had issued a complete response letter rejecting the company’s new drug application (NDA) for oral idebenone to treat Leber hereditary optic neuropathy (LHON)...
US FDA Again Rejects Aldeyra’s Reproxalap for Dry Eye, Citing Trial Failures
Aldeyra Therapeutics reported March 17 that the US FDA had issued a third complete response letter rejecting the company’s new drug application (NDA) for topical reproxalap in dry eye disease. Alde...
Rayner Expands US Headquarters in Memphis Amid Milestone Successes
Rayner reported March 9 that it had opened a new 10 thousand-square-foot facility in Memphis, Tennessee, which will serve as its expanded US headquarters. The UK-based company said the move signifi...
Oertli Launches OS 4 Up Dual-Function Cataract-Vitrectomy System in Europe
Switzerland-based Oertli announced Feb. 23 that its OS 4 Up dual-function cataract/vitrectomy machine is now available in all CE-certified markets. Features include adaptive energy delivery with Ph...
Children’s Hospital Los Angeles Pioneers Aqueous Biopsy Test for Ocular Cancer
Researchers at Children’s Hospital Los Angeles (CHLA) have developed a liquid biopsy test of aqueous humor that they say can significantly improve the diagnosis and clinical management of tumors in...
Science Corp. Leads Latest Fundraising with $230 Million in Series C
Science Corporation led recent ophthalmic fundraising efforts with $230 million in a Series C round to support its Prima implant for dry age-related macular degeneration. Financing announced in the...
Want to Read the Full Article?
Already Have an Account?
Register A Corporate Account
A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.